ORGO — Organogenesis Holdings Share News
0.000.00%
Last trade - 00:00- $127.80m
- $85.28m
- $564.17m
Brief: Organogenesis Achieves Primary Endpoint In Phase 3 Clinical Trial Of Renu For Knee Osteoarthritis
Organogenesis Holdings Inc reports results for the quarter ended in December - Earnings Summary
Brief: Organogenesis Q4 Revenue USD 99.7 Million
Organogenesis Holdings Inc expected to post earnings of 1 cent a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Expedia Group, Meta Platforms, Rayzebio
Brief: Organogenesis Q3 Revenue USD 108.5 Million
U.S. STOCKS ON THE MOVE-Air Transport Services Group, Dillard's, Precigen
U.S. STOCKS ON THE MOVE-Capri Holdings, Amyris, gold miners
U.S. STOCKS ON THE MOVE-YETI Holdings, Catalyst Pharma, ZimVie
Organogenesis Holdings slumps after withdrawing 2023 guidance
Organogenesis Holdings Inc reports results for the quarter ended in June - Earnings Summary
Brief: Organogenesis Q2 Revenue USD 117.3 Million
Organogenesis Holdings Inc expected to post earnings of 3 cents a share - Earnings Preview
Organogenesis hits 9-month high over BTIG rating upgrade
U.S. RESEARCH ROUNDUP-Empire State, Integra Lifesciences, Lowe's Companies
Organogenesis soars on upbeat 2023 forecast, Q1 results
Organogenesis Holdings Inc reports results for the quarter ended in March - Earnings Summary
Brief: Organogenesis Holdings Inc Reports First Quarter 2023 Financial Results
Brief: Organogenesis Q1 Adjusted EBITDA USD 3.8 Mln